CMS announced its final notice for the Transitional Coverage for Emerging Technologies (TCET) pathway, which would expedite Medicare coverage of...
Read More
Survey Assessing the Environment for Developing Treatments for Rare Diseases
August 7, 2024
In partnership with the Save Rare Treatments Task Force, CLS is conducting a survey of our membership to gather feedback...
Read More
CLS Response to House RFI on 21st Century Cures Initiative
August 7, 2024
CLS has prepared comments in response to Reps. DeGette’s (D-CO) and Bucshon’s (R-IN) Request for Information on the next iteration of...
Read More
CLS Comments on NIH Proposed Policy That Would Require Access Plans in Licensing Agreements
July 24, 2024
CLS has prepared comments in response to NIH’s proposed policy that would make licensing agreements for NIH owned inventions conditional...
Read More
MedTechColor & California Life Sciences Announce Partnership
June 11, 2024
California Life Sciences has continued its partnership with MedTech Color (MTC), the nation's leading nonprofit organization that's on a mission...
Read More
The Promise and Potential of AI in Life Sciences | Opinion by Mike Guerra for NEWSWEEK
June 10, 2024
California is a national leader in innovation. This position is no more apparent than in the life sciences, where the...
Read More
CLS and Thrive Scholars Launch Collaboration Agreement to Support Students of Color Excel in STEM Careers
June 10, 2024
Through our commitment to creating a more diverse, inclusive, and equitable industry, CLS has built a network of partners around...
Read More
FAST Alum Presenting at BIO International Convention Start-Up Stadium
June 6, 2024
Congratulations to FAST alumni, Aluda Pharmaceuticals Inc., GelSana and Isosterix and Matrubials Inc. for showcasing their innovative solutions at Startup...
Read More
Advocating for Congress to Establish a Rare Disease Center of Excellence
June 5, 2024
CLS joined the EveryLife Foundation in sending a letter to Congress, advocating for the inclusion of report language to establish...
Read More
LABEST 2024
May 24, 2024
We had an amazing time at LABEST 2024! The event was a fantastic showcase of bioscience innovation, featuring groundbreaking presentations...
Read More
Amplifying Concerns with White House “March-In” Framework
May 24, 2024
As an advocate for strong life sciences intellectual property rights and a member of the Bayh Dole Coalition, CLS is...
Read More
CMS Drops “Stacking” Provision in MDRP Rule
May 24, 2024
In a major win for the life sciences industry, we were pleased to see CMS release a statement last week...
Read More
